Adam C Celio1, Kevin R Kasten1, Matthew B Burruss1, Walter J Pories1, Konstantinos Spaniolas2. 1. Department of Surgery, Brody School of Medicine at East Carolina University, 600 Moye Blvd, Greenville, NC, 27834, USA. 2. Department of Surgery, Brody School of Medicine at East Carolina University, 600 Moye Blvd, Greenville, NC, 27834, USA. spaniolask@ecu.edu.
Abstract
BACKGROUND: Laparoscopic Roux-en-Y gastric bypass (LRYGB) is a commonly performed bariatric procedure. Readmissions are used as a quality indicator with a nationwide emphasis on reduction. In LRYGB surgery, surgeon volume studies have focused on correlation with technical outcomes, offering limited data on readmissions. Our aim was to evaluate nationwide data to explore the relationship between surgeon case volume and hospital readmissions following LRYGB. METHODS: The Bariatric Outcomes Longitudinal Database from 2011 was used for this study. Analysis was restricted to patients who underwent non-revisional LRYGB. Surgeons performing more than 50 LRYGB during the study period were defined as high-volume surgeons (HVS). Multivariable logistic regression modeling was used to control for patient demographics and comorbidities. RESULTS: We identified 32,521 patients who underwent LRYGB with an overall 30-day readmission rate of 5.5 %, mean age 45.7 (12.0) years, and mean BMI 47.2 (8.0) kg/m2. There were no major differences in BMI (47.3 ± 8.1 vs 47.1 ± 7.9, p = 0.282) or age (45.5 ± 12.0 vs 45.8 ± 12.0, p = 0.030) between low-volume surgeon (LVS) and HVS patients. After controlling for baseline characteristics, HVS patients were less likely to be readmitted compared to those with a LVS (OR = 0.85, 95 % CI 0.77-0.94), with a readmission rate of 5.2 vs 6.1 % (p = 0.001). Additionally, HVS patients had lower rates of 30-day mortality (OR = 0.50, 95 % CI 0.27-0.91), complication (OR = 0.81, 95 % CI 0.75-0.87), reoperation (OR = 0.82, 95 % CI 0.72-0.93), and anastomotic leak (OR = 0.64, 95 % CI 0.46-0.87). CONCLUSIONS: Readmission following LRYGB is significantly associated with surgeon operative volume; surgeons that perform fewer than 50 LRYGB per year are more likely to have 30-day readmissions and complications. Our findings support other more generalized studies suggesting surgeon case volume is inversely associated with increased risk of adverse outcomes and complications. As such, performance of LRYGB by HVS may decrease patient morbidity, hospital readmission, and overall healthcare utilization.
BACKGROUND: Laparoscopic Roux-en-Y gastric bypass (LRYGB) is a commonly performed bariatric procedure. Readmissions are used as a quality indicator with a nationwide emphasis on reduction. In LRYGB surgery, surgeon volume studies have focused on correlation with technical outcomes, offering limited data on readmissions. Our aim was to evaluate nationwide data to explore the relationship between surgeon case volume and hospital readmissions following LRYGB. METHODS: The Bariatric Outcomes Longitudinal Database from 2011 was used for this study. Analysis was restricted to patients who underwent non-revisional LRYGB. Surgeons performing more than 50 LRYGB during the study period were defined as high-volume surgeons (HVS). Multivariable logistic regression modeling was used to control for patient demographics and comorbidities. RESULTS: We identified 32,521 patients who underwent LRYGB with an overall 30-day readmission rate of 5.5 %, mean age 45.7 (12.0) years, and mean BMI 47.2 (8.0) kg/m2. There were no major differences in BMI (47.3 ± 8.1 vs 47.1 ± 7.9, p = 0.282) or age (45.5 ± 12.0 vs 45.8 ± 12.0, p = 0.030) between low-volume surgeon (LVS) and HVS patients. After controlling for baseline characteristics, HVS patients were less likely to be readmitted compared to those with a LVS (OR = 0.85, 95 % CI 0.77-0.94), with a readmission rate of 5.2 vs 6.1 % (p = 0.001). Additionally, HVS patients had lower rates of 30-day mortality (OR = 0.50, 95 % CI 0.27-0.91), complication (OR = 0.81, 95 % CI 0.75-0.87), reoperation (OR = 0.82, 95 % CI 0.72-0.93), and anastomotic leak (OR = 0.64, 95 % CI 0.46-0.87). CONCLUSIONS: Readmission following LRYGB is significantly associated with surgeon operative volume; surgeons that perform fewer than 50 LRYGB per year are more likely to have 30-day readmissions and complications. Our findings support other more generalized studies suggesting surgeon case volume is inversely associated with increased risk of adverse outcomes and complications. As such, performance of LRYGB by HVS may decrease patient morbidity, hospital readmission, and overall healthcare utilization.
Authors: John Saunders; Garth H Ballantyne; Scott Belsley; Daniel J Stephens; Amit Trivedi; Douglas R Ewing; Vincent A Iannace; Rafael F Capella; Annette Wasileweski; Steven Moran; Hans J Schmidt Journal: Obes Surg Date: 2008-05-02 Impact factor: 4.129
Authors: Brian Hong; Edwin Stanley; Susan Reinhardt; Kristen Panther; Michael J Garren; Jon C Gould Journal: Surg Obes Relat Dis Date: 2011-06-15 Impact factor: 4.734
Authors: Guilherme M Campos; Ruxandra Ciovica; Stanley J Rogers; Andrew M Posselt; Eric Vittinghoff; Mark Takata; John P Cello Journal: Arch Surg Date: 2007-10
Authors: Robert B Dorman; Christopher J Miller; Daniel B Leslie; Federico J Serrot; Bridget Slusarek; Henry Buchwald; John E Connett; Sayeed Ikramuddin Journal: PLoS One Date: 2012-03-07 Impact factor: 3.240
Authors: Jerry T Dang; Iran Tavakoli; Noah Switzer; Valentin Mocanu; Xinzhe Shi; Chris de Gara; Daniel W Birch; Shahzeer Karmali Journal: Can J Surg Date: 2020-04-17 Impact factor: 2.089
Authors: Kristina H Lewis; David E Arterburn; Katherine Callaway; Fang Zhang; Stephanie Argetsinger; Jamie Wallace; Adolfo Fernandez; Dennis Ross-Degnan; James F Wharam Journal: JAMA Netw Open Date: 2019-12-02